Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy.

ABSTRACT:

SUBMITTER: Deumelandt K 

PROVIDER: S-EPMC5761563 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature